Dublin, Oct. 18, 2016 -- Research and Markets has announced the addition of the "Drug Injection Devices to 2024" report to their offering.
What You Will Learn
- What are the dynamics of the shifting landscape for injectable drug delivery and the market impact of new and evolving syringes and injectors by therapeutic indication?
- What are the market drivers influencing syringe and injector device designs, feature/functionality, product branding, competing technologies and commercial development?
- What are the key characteristics of the major injection device market segments and what is the impact of market demographics, and competing business strategies?
- What is the current market for syringe and injector demand by indication and therapy and what will it be in 2024?
- Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
- What is the impact of economic, technology, and regulatory factors on injectable drug delivery demand?
The correlation between chronic conditions and the benefits of patient self-administration continues to influence therapeutic product decisions, managed care initiatives and regulatory actions. Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research.
Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process.
Key Topics Covered:
1. Executive Summary
2. Drug Injection Device Market Dynamics
- Evolution in Injectable Drug Development
- Injectable Drug Demand Drivers
- Diseases and Indications
3. Chronic Conditions & Self-Administration - Technology Factors
- Device Selection Factors
- Market Segmentation
- Product Features & Ease of Use
- Competitive Landscape
- Injection Device Suppliers - Capabilities and Market Presence
4. Commercial Injection Device Classes - Strategic Analysis
- Autoinjectors
- Dual Chamber Syringes
- Needle-free Injectors
- Pen Injectors
- Prefilled Syringes
- Safety Syringes
- Patch Pumps
- Subcutaneous Infusion Devices
- Risks and Opportunities
5. Injection Device Selection Criteria
- Stability and Material Selection Issues
- Fixed vs Variable Dose Devices
- Lyophilized Drugs/Reconstitution
- Syringe Safety/Sharps Protection
- Needle Configuration Strategies
- Disposable Drug Cartridges
- Human Engineering/Ergonomics
- Branding/Private Labeling
6. Drug Injection Device Market Segment Analysis & Forecasts
- Anticoagulants
- Antivirals
- Autoimmune Diseases
- Diabetes
- Emergency Medicine
- Hematopoietics
- Hormone Replacement
- Neurology
- Osteoporosis
- Reproductive Health
- Vaccines
7. Injectable Drug Therapeutics - Market Factors
8. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/399mnn/drug_injection
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables , Needles and Syringes


John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 



